今开:29.19 | 昨收:29.12 |
最高:29.27 | 最低:28.815 |
涨停价:0.0 | 跌停价:0.0 |
总市值:1.630212511E9 |
产业链观察01-03 20:43
#药闻简讯# $Agios制药(AGIO)$ 对非输血依赖型阿尔法或贝塔地中海贫血成人患者进行的 Mitapivat 3 期 ENERGIZE 研究达到了主要终点和两个关键次要终点。关键次要终点也具有统计学意义查看全文
产业链观察01-04 09:20
#药闻简讯# 2024年1月3日(美国密歇根州)细胞代谢领域的领先企业、罕见病治疗领域的开拓者$Agios制药(AGIO)$ 今天宣布,针对非输血依赖型(NTD)α-或β-地中海贫血成人患者的米他米韦全球3期ENERGIZE研究达到了血红蛋白反应的主要终点。 FACIT-疲劳评分和血红蛋白浓度与基线相比的变化这两个关键...查看全文
Agios制药(AGIO)2023-08-12 04:15
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-23-000125 Size: 9 KB 网页链接查看全文
Agios制药(AGIO)2023-07-01 04:15
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-23-000107 Size: 8 KB 网页链接查看全文
Agios制药(AGIO)2023-05-04 19:06
$Agios制药(AGIO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001439222-23-000063 Act: 34 Size: 325 KB 网页链接查看全文
Agios制药(AGIO)2023-02-23 23:42
$Agios制药(AGIO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001439222-23-000039 Act: 34 Size: 11 MB 网页链接查看全文
Agios制药(AGIO)2023-02-15 01:51
$Agios制药(AGIO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000080255-23-002609 Act: 34 Size: 7 KB 网页链接查看全文
Agios制药(AGIO)2023-02-15 05:28
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-23-000017 Size: 8 KB 网页链接查看全文
Agios制药(AGIO)2022-11-03 19:06
$Agios制药(AGIO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001439222-22-000098 Act: 34 Size: 349 KB 网页链接查看全文
Agios制药(AGIO)03-08 07:55
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000058 Size: 7 KB 网页链接查看全文
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000061 Size: 5 KB 网页链接
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000056 Size: 4 KB 网页链接
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000058 Size: 7 KB 网页链接
$Agios制药(AGIO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-002026 Act: 33 Size: 6 KB 网页链接
$Agios制药(AGIO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-001982 Act: 33 Size: 6 KB 网页链接
$Agios制药(AGIO)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-001926 Act: 33 Size: 5 KB 网页链接
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000050 Size: 16 KB 网页链接
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000052 Size: 13 KB 网页链接
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000054 Size: 18 KB 网页链接
$Agios制药(AGIO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001439222-24-000044 Size: 7 KB 网页链接